Phong Phu Pharmaceutical JSC

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: VN000000PPP8
VND
18,600.00
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
37,438.09
41,347.32
32,511.43
31,081.18
34,890.84
36,499.50
33,417.09
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
37,438.09
41,347.32
32,511.43
31,081.18
34,890.84
36,499.50
33,417.09
Raw Material Cost
22,847.39
26,309.14
21,337.27
19,940.43
22,914.71
23,501.04
21,077.90
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
4,181.28
4,561.46
3,754.17
3,902.84
3,647.31
3,725.76
3,665.47
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
61.01
44.84
16.37
23.97
0.00
0.00
0.00
Selling and Distribution Expenses
6,996.66
8,086.87
7,155.64
6,466.58
6,420.01
6,833.28
6,490.74
Other Expenses
-424.23
-460.63
-377.05
-392.68
-364.73
-372.58
-366.55
Total Expenditure (Excl Depreciation)
29,844.05
34,396.02
28,492.91
26,407.01
29,334.72
30,334.31
27,568.65
Operating Profit (PBDIT) excl Other Income
7594
6951.3
4018.5
4674.2
5556.1
6165.2
5848.400000000001
Other Income
5,997.96
1,149.43
100.24
730.89
101.21
729.10
84.45
Operating Profit (PBDIT)
14,741.26
8,100.74
5,123.43
6,413.04
6,664.25
7,899.14
6,934.92
Interest
61.01
44.84
16.37
23.97
0.00
0.00
0.00
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
14,590.70
15,038.17
11,174.16
11,140.75
11,976.13
12,998.46
12,339.18
Depreciation
1,149.26
0.00
1,004.68
1,007.98
1,006.92
1,004.86
1,002.03
Profit Before Tax
13,530.99
8,055.90
4,102.39
5,381.09
5,657.33
6,894.29
5,932.89
Tax
2,719.69
1,626.97
821.54
1,061.90
1,131.47
1,462.00
1,224.41
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
10,811.30
6,428.93
3,280.85
4,319.19
4,525.87
5,432.28
4,708.48
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
10,811.30
6,428.93
3,280.85
4,319.19
4,525.87
5,432.28
4,708.48
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
10,811.30
6,428.93
3,280.85
4,319.19
4,525.87
5,432.28
4,708.48
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
10000.0
10000.0
10000.0
10000.0
10000.0
10000.0
10000.0
Reserves
1,48,469.13
1,38,729.58
1,32,908.21
1,30,059.40
1,39,396.20
1,35,358.12
1,30,478.53
Earnings per share (EPS)
1228.56
0.0
372.82
490.82
514.3
617.31
535.05
Diluted Earnings per share
1228.56
0.0
372.82
490.82
514.3
617.31
535.05
Operating Profit Margin (Excl OI)
20.28%
16.81%
12.36%
15.04%
15.92%
16.89%
17.5%
Gross Profit Margin
39.21%
19.48%
15.71%
20.56%
19.1%
21.64%
20.75%
PAT Margin
28.88%
15.55%
10.09%
13.9%
12.97%
14.88%
14.09%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Mar 2026 is 7.30% vs 13.48% in Mar 2025

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Mar 2026 is 138.88% vs 73.19% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Mar 2026 is 33.22% vs 59.13% in Mar 2025

stock-summary

Interest

YoY Growth in quarter ended Mar 2026 is 0.00% vs 0.00% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025

Compare Quarterly Results Of Phong Phu Pharmaceutical JSC With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(VND)
Change(%)
Net Sales
37,438.09
0
37,438.09
Other Operating Income
0.00
0.00
0.00
Total Operating income
37,438.09
0
37,438.09
Raw Material Cost
22,847.39
0
22,847.39
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
4,181.28
0
4,181.28
Power Cost
0
0
0.00
Manufacturing Expenses
61.01
0
61.01
Selling and Distribution Expenses
6,996.66
0
6,996.66
Other Expenses
-424.23
0.00
-424.23
Total Expenditure (Excl Depreciation)
29,844.05
0
29,844.05
Operating Profit (PBDIT) excl Other Income
7,594.04
0.00
7,594.04
Other Income
5,997.96
0
5,997.96
Operating Profit (PBDIT)
14,741.26
0
14,741.26
Interest
61.01
0
61.01
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
14,590.70
0
14,590.70
Depreciation
1,149.26
0
1,149.26
Profit Before Tax
13,530.99
0
13,530.99
Tax
2,719.69
0
2,719.69
Provisions and contingencies
0
0
0.00
Profit After Tax
10,811.30
0
10,811.30
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
10,811.30
0
10,811.30
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
10,811.30
0
10,811.30
Equity Capital
0
0
0.00
Face Value
10,000.00
0
0.00
Reserves
1,48,469.13
0
1,48,469.13
Earnings per share (EPS)
1,228.56
0
1,228.56
Diluted Earnings per share
1,228.56
0
1,228.56
Operating Profit Margin (Excl OI)
20.28%
0%
0.00
20.28%
Gross Profit Margin
39.21%
0%
0.00
39.21%
PAT Margin
28.88%
0%
0.00
28.88%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 3,743.81 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -9.45% vs 27.18% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 7.30% vs 13.48% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 1,081.13 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 68.17% vs 95.96% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 138.88% vs 73.19% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 874.33 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 25.78% vs 38.38% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 33.22% vs 59.13% in Mar 2025

Quarterly - Interest
Interest 6.10 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 36.16% vs 173.17% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 0.00% vs 0.00% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 20.28%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025